Trump Signs Order to Lower Drug Prices in the U.S.
President Trump signs order to reduce high prescription drug costs in the U.S. Impact on healthcare providers, pharmaceutical companies, and patients. Astiva Health and BioMedWire provide insights.
This news matters as it highlights the ongoing efforts to address the high cost of prescription drugs in the U.S. The uncertainty surrounding the methods and long-term effects of the order could impact healthcare providers, pharmaceutical companies, and patients alike.
